Vaishali Pharma Limited

NSE:VAISHALI.NS

192.25 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 180.798323.96278.954125.656134.227268.098199.979131.59196.644215.575221.792198.61481.385177.277212.672100.29934.563200.298101.747103.85181.975277.256277.25698.19998.199224.35224.35114.47114.47
Cost of Revenue 151.978330.862246.1782.50299.229238.262151.24291.84765.425231.622176.215164.34562.823177.247176.5477.35330.376175.81282.06780.96172.052262.152262.15281.32281.322201.511201.51198.16898.168
Gross Profit 28.82-6.90232.78443.15434.99829.83648.73739.74431.219-16.04745.57734.26918.5620.0336.13222.9464.18724.48619.6822.899.92315.10415.10416.87716.87722.8422.8416.30316.303
Gross Profit Ratio 0.159-0.0210.1180.3430.2610.1110.2440.3020.323-0.0740.2050.1730.22800.170.2290.1210.1220.1930.220.0550.0540.0540.1720.1720.1020.1020.1420.142
Reseach & Development Expenses 00000000000000000000000000000
General & Administrative Expenses 000005.9950006.80600023.34900041.6160004.9784.978006.7276.72700
Selling & Marketing Expenses 000005.2920000.860000.6630002.10001.0061.006002.1792.17900
SG&A 6.57262.314.49810.7025.39311.2878.7648.3569.3427.66616.7686.2362.98624.0124.5294.494.56143.7163.0576.6253.3615.9845.9847.227.228.9078.9075.0035.003
Other Expenses 4.24504.6972.9783.6075.2965.2947.3544.343-16.234.0743.6495.667-10.8343.1113.735.417008.499000000000
Operating Expenses 6.57262.314.49817.82213.1123.55214.37815.23710.118-27.99122.73613.1276.884-3.610.21611.1315.14-0.79910.58717.4824.06811.57311.5737.6917.69118.2718.277.527.52
Operating Income 22.248-69.21228.28628.3121.88811.5839.65331.86125.44413.12226.91524.79117.3559.36329.02715.5454.47438.969.09313.9065.775.065.06448.8548.8543.8423.842
Operating Income Ratio 0.123-0.2140.1010.2250.1630.0430.1980.2420.2630.0610.1210.1250.2130.0530.1360.1550.1290.1950.0890.1340.0320.0180.0180.0410.0410.0390.0390.0340.034
Total Other Income Expenses Net 0.4545.0480.349-4.711-0.697-5.359-4.159-5.273-5.294-6.781-5.484-6.105-6.53-29.031-5.863-5.13-4.441-49.65-5.717-6.087-5.69-1.54-1.54-1.858-1.858-3.649-3.649-2.319-2.319
Income Before Tax 22.702-64.16428.63523.59921.1916.22135.49426.58820.156.34121.43118.68610.825-19.66823.16410.4150.033-10.693.3767.8190.083.523.522.1432.1435.2045.2041.5231.523
Income Before Tax Ratio 0.126-0.1980.1030.1880.1580.0230.1770.2020.2080.0290.0970.0940.133-0.1110.1090.1040.001-0.0530.0330.07500.0130.0130.0220.0220.0230.0230.0130.013
Income Tax Expense 5.712-17.3397.5166.5635.3321.8668.8746.6475.0374.3125.3594.6712.706-5.1826.0492.7080.01-2.5220.9322.0330.0211.5051.5050.5890.5892.2992.2990.4410.441
Net Income 16.99-46.82521.11917.03615.8594.36126.6219.94115.1132.02816.07214.0158.119-14.48517.2157.7070.033-8.1682.4445.7860.0592.0142.0141.5541.5542.9052.9051.0831.083
Net Income Ratio 0.094-0.1450.0760.1360.1180.0160.1330.1520.1560.0090.0720.0710.1-0.0820.0810.0770.001-0.0410.0240.05600.0070.0070.0160.0160.0130.0130.0090.009
EPS 1.4-4.371.991.611.50.412.521.891.430.191.521.330.77-1.371.630.730.01-0.760.230.550.010.190.190.150.150.270.270.140.14
EPS Diluted 1.38-4.371.891.521.410.062.521.891.430.191.521.330.77-1.371.630.730.01-0.760.230.550.010.190.190.150.150.270.270.140.14
EBITDA 23.44-67.80729.52829.54626.69313.10140.84833.30626.32714.62127.94125.8118.37410.49230.08716.5995.5142.2549.69314.8936.4345.7245.6814.6224.6229.4759.524.5084.508
EBITDA Ratio 0.13-0.2090.1060.2350.1990.0490.2040.2530.2720.0680.1260.130.2260.0590.1410.1650.1590.2110.0950.1430.0350.0210.020.0470.0470.0420.0420.0390.039